Progression to advanced neoplasia is infrequent in post colectomy familial adenomatous polyposis patients under endoscopic surveillance

Ferga C. Gleeson, Georgios I. Papachristou, Douglas L. Riegert-Johnson, Anne Marie Boller, Christopher J. Gostout

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background and Study Aims Advanced neoplasia may occur in the remaining colon and distal ileum of familial adenomatous polyposis (FAP) patients who have had a prophylactic colon resection. The role of post operative lower GI endoscopic surveillance and management of advanced neoplasia in FAP patients is not well defined. The aims of this study were to determine the prevalence of post operative neoplasia and to evaluate the safety and effectiveness of lower GI endoscopic surveillance and ablative therapy following prophylactic colon resection. Patients and Methods A retrospective analysis of 42 FAP patients with prior primary colon cancer preventative surgery undergoing lower GI surveillance and ablative therapy from 1992 to 2006. Results All patients had adenomatous disease identified upon initial endoscopy with advanced neoplasia identified in 6/42 (14%). Patients had a median of 4 endoscopic procedures of which 2 (range 0-12) were therapeutic, over a 49 month follow-up period (range 0-168) Thermal ablation with argon plasma coagulation, polypectomy and surgical intervention were required in 55%, 7% and 14% of patients. Ablative therapy complications were due to Nd: YAG laser and snare polypectomy (5%). Progression to advanced neoplasia from baseline pathology occurred despite ablative therapy in 3/42 (7%) patients. We propose a lower GI tract endoscopic surveillance program for post surgical FAP patients. Conclusion Despite prophylactic colon surgery, FAP patients continue to be at risk of neoplasia. The development of advanced neoplasia is infrequent in patients embarking upon endoscopic surveillance. Ablative therapy is effective and safe for the vast majority of FAP patients.

Original languageEnglish (US)
Pages (from-to)33-38
Number of pages6
JournalFamilial Cancer
Volume8
Issue number1
DOIs
StatePublished - Mar 2009

Fingerprint

Adenomatous Polyposis Coli
Colectomy
Neoplasms
Colon
Therapeutics
Argon Plasma Coagulation
Lower Gastrointestinal Tract
Solid-State Lasers
Ileum
Colonic Neoplasms
Endoscopy
Hot Temperature

Keywords

  • Advanced adenoma
  • Colon cancer prevention
  • Endoscopic surveillance
  • Familial adenomatous polyposis
  • Polyp burden
  • Thermal ablation

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Oncology
  • Genetics(clinical)

Cite this

Progression to advanced neoplasia is infrequent in post colectomy familial adenomatous polyposis patients under endoscopic surveillance. / Gleeson, Ferga C.; Papachristou, Georgios I.; Riegert-Johnson, Douglas L.; Boller, Anne Marie; Gostout, Christopher J.

In: Familial Cancer, Vol. 8, No. 1, 03.2009, p. 33-38.

Research output: Contribution to journalArticle

Gleeson, Ferga C. ; Papachristou, Georgios I. ; Riegert-Johnson, Douglas L. ; Boller, Anne Marie ; Gostout, Christopher J. / Progression to advanced neoplasia is infrequent in post colectomy familial adenomatous polyposis patients under endoscopic surveillance. In: Familial Cancer. 2009 ; Vol. 8, No. 1. pp. 33-38.
@article{a9371dd5f5c444489bb7b8e13b588a6b,
title = "Progression to advanced neoplasia is infrequent in post colectomy familial adenomatous polyposis patients under endoscopic surveillance",
abstract = "Background and Study Aims Advanced neoplasia may occur in the remaining colon and distal ileum of familial adenomatous polyposis (FAP) patients who have had a prophylactic colon resection. The role of post operative lower GI endoscopic surveillance and management of advanced neoplasia in FAP patients is not well defined. The aims of this study were to determine the prevalence of post operative neoplasia and to evaluate the safety and effectiveness of lower GI endoscopic surveillance and ablative therapy following prophylactic colon resection. Patients and Methods A retrospective analysis of 42 FAP patients with prior primary colon cancer preventative surgery undergoing lower GI surveillance and ablative therapy from 1992 to 2006. Results All patients had adenomatous disease identified upon initial endoscopy with advanced neoplasia identified in 6/42 (14{\%}). Patients had a median of 4 endoscopic procedures of which 2 (range 0-12) were therapeutic, over a 49 month follow-up period (range 0-168) Thermal ablation with argon plasma coagulation, polypectomy and surgical intervention were required in 55{\%}, 7{\%} and 14{\%} of patients. Ablative therapy complications were due to Nd: YAG laser and snare polypectomy (5{\%}). Progression to advanced neoplasia from baseline pathology occurred despite ablative therapy in 3/42 (7{\%}) patients. We propose a lower GI tract endoscopic surveillance program for post surgical FAP patients. Conclusion Despite prophylactic colon surgery, FAP patients continue to be at risk of neoplasia. The development of advanced neoplasia is infrequent in patients embarking upon endoscopic surveillance. Ablative therapy is effective and safe for the vast majority of FAP patients.",
keywords = "Advanced adenoma, Colon cancer prevention, Endoscopic surveillance, Familial adenomatous polyposis, Polyp burden, Thermal ablation",
author = "Gleeson, {Ferga C.} and Papachristou, {Georgios I.} and Riegert-Johnson, {Douglas L.} and Boller, {Anne Marie} and Gostout, {Christopher J.}",
year = "2009",
month = "3",
doi = "10.1007/s10689-008-9203-y",
language = "English (US)",
volume = "8",
pages = "33--38",
journal = "Familial Cancer",
issn = "1389-9600",
publisher = "Springer Netherlands",
number = "1",

}

TY - JOUR

T1 - Progression to advanced neoplasia is infrequent in post colectomy familial adenomatous polyposis patients under endoscopic surveillance

AU - Gleeson, Ferga C.

AU - Papachristou, Georgios I.

AU - Riegert-Johnson, Douglas L.

AU - Boller, Anne Marie

AU - Gostout, Christopher J.

PY - 2009/3

Y1 - 2009/3

N2 - Background and Study Aims Advanced neoplasia may occur in the remaining colon and distal ileum of familial adenomatous polyposis (FAP) patients who have had a prophylactic colon resection. The role of post operative lower GI endoscopic surveillance and management of advanced neoplasia in FAP patients is not well defined. The aims of this study were to determine the prevalence of post operative neoplasia and to evaluate the safety and effectiveness of lower GI endoscopic surveillance and ablative therapy following prophylactic colon resection. Patients and Methods A retrospective analysis of 42 FAP patients with prior primary colon cancer preventative surgery undergoing lower GI surveillance and ablative therapy from 1992 to 2006. Results All patients had adenomatous disease identified upon initial endoscopy with advanced neoplasia identified in 6/42 (14%). Patients had a median of 4 endoscopic procedures of which 2 (range 0-12) were therapeutic, over a 49 month follow-up period (range 0-168) Thermal ablation with argon plasma coagulation, polypectomy and surgical intervention were required in 55%, 7% and 14% of patients. Ablative therapy complications were due to Nd: YAG laser and snare polypectomy (5%). Progression to advanced neoplasia from baseline pathology occurred despite ablative therapy in 3/42 (7%) patients. We propose a lower GI tract endoscopic surveillance program for post surgical FAP patients. Conclusion Despite prophylactic colon surgery, FAP patients continue to be at risk of neoplasia. The development of advanced neoplasia is infrequent in patients embarking upon endoscopic surveillance. Ablative therapy is effective and safe for the vast majority of FAP patients.

AB - Background and Study Aims Advanced neoplasia may occur in the remaining colon and distal ileum of familial adenomatous polyposis (FAP) patients who have had a prophylactic colon resection. The role of post operative lower GI endoscopic surveillance and management of advanced neoplasia in FAP patients is not well defined. The aims of this study were to determine the prevalence of post operative neoplasia and to evaluate the safety and effectiveness of lower GI endoscopic surveillance and ablative therapy following prophylactic colon resection. Patients and Methods A retrospective analysis of 42 FAP patients with prior primary colon cancer preventative surgery undergoing lower GI surveillance and ablative therapy from 1992 to 2006. Results All patients had adenomatous disease identified upon initial endoscopy with advanced neoplasia identified in 6/42 (14%). Patients had a median of 4 endoscopic procedures of which 2 (range 0-12) were therapeutic, over a 49 month follow-up period (range 0-168) Thermal ablation with argon plasma coagulation, polypectomy and surgical intervention were required in 55%, 7% and 14% of patients. Ablative therapy complications were due to Nd: YAG laser and snare polypectomy (5%). Progression to advanced neoplasia from baseline pathology occurred despite ablative therapy in 3/42 (7%) patients. We propose a lower GI tract endoscopic surveillance program for post surgical FAP patients. Conclusion Despite prophylactic colon surgery, FAP patients continue to be at risk of neoplasia. The development of advanced neoplasia is infrequent in patients embarking upon endoscopic surveillance. Ablative therapy is effective and safe for the vast majority of FAP patients.

KW - Advanced adenoma

KW - Colon cancer prevention

KW - Endoscopic surveillance

KW - Familial adenomatous polyposis

KW - Polyp burden

KW - Thermal ablation

UR - http://www.scopus.com/inward/record.url?scp=59449108965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59449108965&partnerID=8YFLogxK

U2 - 10.1007/s10689-008-9203-y

DO - 10.1007/s10689-008-9203-y

M3 - Article

C2 - 18649121

AN - SCOPUS:59449108965

VL - 8

SP - 33

EP - 38

JO - Familial Cancer

JF - Familial Cancer

SN - 1389-9600

IS - 1

ER -